Chinese Journal of Tissue Engineering Research ›› 2018, Vol. 22 ›› Issue (9): 1419-1424.doi: 10.3969/j.issn.2095-4344.0474

Previous Articles     Next Articles

Effects of brain-derived neurotrophic factor-modified human amniotic membrane-derived mesenchymal stem cell transplantation on learning and memory abilities of Alzheimer's disease rats

Gao Ming-long1, Shi Shao-xia1, Zhang Kun1, Zhang Ying-dong1, Li Na1, Yu Ming1, Wang Yong-liang1, 2   

  1. 1Department of Psychiatry, First Affiliated Hospital of Hebei Medical University, Shijiazhuang 050031, Hebei Province, China; 2Hebei Provincial Institute of Mental Health/ Hebei Provincial Key Laboratory of Aging and Cognitive Psychology, Shijiazhuang 050031, Hebei Province, China
  • Revised:2018-01-19 Online:2018-03-28 Published:2018-04-03
  • Contact: Wang Yong-liang, Master, Attending physician, Department of Psychiatry, First Affiliated Hospital of Hebei Medical University, Shijiazhuang 050031, Hebei Province, China; Hebei Provincial Institute of Mental Health/Hebei Provincial Key Laboratory of Aging and Cognitive Psychology, Shijiazhuang 050031, Hebei Province, China
  • About author:Gao Ming-long, Master, Attending physician, Department of Psychiatry, First Affiliated Hospital of Hebei Medical University, Shijiazhuang 050031, Hebei Province, China
  • Supported by:

    the Scientific Research Project of Hebei Provincial Health Department, No. ZL20140099; the project funded by the Hebei Provincial Health Department, No. 20130578

Abstract:

BACKGROUND: A variety of stem cells have been found to be effective in the treatment of Alzheimer's disease in rats. However, few reports have been reported on the treatment of Alzheimer's disease rats with brain-derived neurotrophic factor (BDNF)-modified human amniotic membrane-derived mesenchymal stem cells.
OBJECTIVE: To investigate the effects of BDNF-modified human amniotic membrane-derived mesenchymal stem cell transplantation on the learning and memory abilities of Alzheimer's disease rats.
METHODS: Forty-eight Sprague-Dawley rats were divided into control group (no treatment), model group (Alzheimer's disease model), stem cell transplantation group (human amniotic membrane-derived mesenchymal stem cell transplantation+Alzheimer's disease model) and BDNF-modified stem cell transplantation group (BDNF-modified human amniotic membrane-derived mesenchymal stem cell transplantation+Alzheimer's disease model), 12 rats in each group. Learning and memory of model rats were determined in a trisection radiation maze and immunohistochemical staining was used to determine the number of p75 positive neurons at 2 weeks after cell transplantation.
RESULTS AND CONCLUSION: The number of p75 positive neurons in the bevel zone and medial septal nucleus was ranked as follows: the model group < the stem cell transplantation group < the BDNF-modified stem cell transplantation group < the control group, and there were significant differences among groups (P < 0.05). The learning and memory abilities of the rats were ranked as follows: the model group < the stem cell transplantation group < the BDNF-modified stem cell transplantation group < the control group, and there were significant differences among groups (P < 0.05). In the BDNF-modified stem cell transplantation group, the number of learnings was negatively correlated with the number of p75 NGFR-positive neurons (P < 0.05), while the memory capacity was positively correlated with the number of p75 NGFR-positive neurons (P < 0.05). These findings reveal that human amniotic membrane-derived mesenchymal stem cell transplantation can improve learning and memory abilities of Alzheimer's disease rats, and BDNF-modified human amniotic membrane-derived mesenchymal stem cells can further improve this therapeutic effect.

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

Key words: Amnion, Mesenchymal Stem Cell Transplantation, Brain-Derived Neurotrophic Factor, Alzheimer Disease, Learning, Memory, Receptor, Nerve Growth Factor, Tissue Engineering

CLC Number: